Medtronic plc (ETR:2M6)
Germany
· Delayed Price · Currency is EUR | Market Cap | 94.39B |
| Revenue (ttm) | 29.51B |
| Net Income (ttm) | 4.10B |
| Shares Out | n/a |
| EPS (ttm) | 3.18 |
| PE Ratio | 23.01 |
| Forward PE | 15.49 |
| Dividend | 2.60 (3.55%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 870 |
| Average Volume | 981 |
| Open | 73.57 |
| Previous Close | 73.35 |
| Day's Range | 72.52 - 74.55 |
| 52-Week Range | 70.10 - 90.81 |
| Beta | 0.82 |
| RSI | 44.72 |
| Earnings Date | Aug 19, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Looking Into Medtronic's Recent Short Interest
Medtronic's (NYSE: MDT) short percent of float has fallen 42.06% since its last report. The company recently reported that it has 7.88 million shares sold short , which is 0.62% of all regular shares...
6 Upcoming Dividend Increases
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increa...
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-cove...
Medtronic: Solid Recent Performance But Better Options Available
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc (NYSE: MDT) announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial m...
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial minority I...
Medtronic separate diabetes business to be called MiniMed
Medtronic announces MiniMed as name for planned New Diabetes Company
GALWAY, Ireland , June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following ...
5 Things You Need to Know If You Buy Medtronic Today
Medtronic Announces Intent To Spin Diabetes Business
Deal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business in...
Medtronic shares uptick for eight consecutive sessions
Medtronic Just Announced a Move That Its Shareholders Should Love
Caterpillar To Lead Dividend Increases In June As Lowe's Boosted Payout At End Of May
Dividend growth remains robust for select companies, with Casey's, Oil-Dri, and Matson poised for double-digit increases based on strong earnings and expansion. Caterpillar and Kroger are expected to ...
I'm Buying 2 Must-Own Dividend Bargains
The market continues to chase growth while ignoring once beloved income stocks. Verizon offers a compelling 6.3% dividend yield, robust free cash flow, and trades well below its historical valuation, ...
Does This Move Make Medtronic Stock a Buy?
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
Medtronic plc (NYSE:MDT) Bernstein's 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Thierry Pieton - Execut...
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.
Edwards Lifesciences, Medtronic gain as Boston Scientific pulls aortic valve systems
No Rolex For Me - I'm Buying Dividends That Pay For Life
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable ...
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Upgrading Medtronic to 'Strong Buy' with a $104 fair value, driven by the diabetes business spin-off catalyst. Divesting diabetes enables Medtronic to focus on core cardiac and surgical markets, impro...
Notable healthcare headlines for the week: UnitedHealth, Pfizer and Medtronic in focus
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
GALWAY, Ireland , May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conferen...
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets